Healthcare Sales & Marketing Network News: RM-493

Searching News Database: RM-493

HSMN NewsFeed - 11 May 2017
Rhythm Receives Expanded FDA Breakthrough Therapy Designation for Setmelanotide for Rare Genetic Disorders of Obesity
Biopharmaceuticals FDA

HSMN NewsFeed - 5 Jan 2016
Rhythm and Camurus Announce License Agreement for Extended Release FluidCrystal Setmelanotide
Biopharmaceuticals Drug Delivery Licensing

HSMN NewsFeed - 27 Nov 2012
Rhythm Expands Series B Financing to $33 Million; Adds Pfizer Ventures as an Investor
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 13 Jun 2012
Rhythm Raises $25M in Series B Financing for Diabetes and Obesity Therapeutics
Biopharmaceuticals Endocrinology Venture Capital

HSMN NewsFeed - 8 Sep 2010
Rhythm Closes $40 Million Series A Financing
Biopharmaceuticals Venture Capital

Return to NewsFeed

FindReps - screen and connect with rep candidates anonymously, in real time.

FindReps: Screen and connect with Medical Sales Rep candidates (Direct Reps and Independents) – anonymously, in real time.

RepJobs - Job Opportunities for Direct Sales Reps and New Product Lines for Independents!

RepJobs: Job Opportunities for Direct Sales Reps and New Product Lines for Independents!